Sustainability Evaluation and Reporting by Pharmaceutical Companies

• Tipo: Poster em Conferência Internacional
• Data: 2011

Autores

Teresa M. Mata (Autor) FEUP; António A. Martins (Autor) FEUP; Belmira Neto (Autor) FEUP; M. Leonor Martins (Autor) FEUP; C. A. Costa (Autor) FEUP; R. L. R. Salcedo (Autor) FEUP

Conferência Internacional

6th Dubrovnik Conference on Sustainable Development of Energy, Water and Environment Systems (SDEWES)

Dubrovnik, Croácia, 25-29 de Setembro de 2011

Classificação Científica

FOS: Ciências da engenharia e tecnologias > Engenharia do ambiente

CORDIS: Ciências Naturais > Ciências do ambiente > Gestão dos recursos naturais > Protecção ambiental

Outras Informações

Abstract (EN): The awareness of sustainability as a main issue for companies’ performance has grown considerably over the last few years. This study aims to present the recent advances in this field by summarizing the key metric systems that have been proposed for the sustainability evaluation and reporting in the fine chemicals or pharmaceutical industry. Also, it describes how to perform a sustainability evaluation of pharmaceutical products throughout its supply chain. A framework for selecting sustainability indicators that takes into account all three sustainability dimensions (environmental, economic, and societal) is applied, given special attention to the identification of the significant potential environmental, economic, and social impacts associated with a pharmaceutical product’s value chain. A set of sustainability indicators is proposed for the quantitative sustainability evaluation of pharmaceutical products and processes, based on the relevant impacts identified for each supply chain stage.

Idioma: Inglês

Tipo (Avaliação Docente): Científica